TrialPanorama/TrialPanorama-database huggingface dataset:
Study 8842353 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15951466 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study 24371021 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 17700217 — Surrogate Endpoint (SUR): Blood pressure
Study 15334764 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 28329386 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 12658059 — Surrogate Endpoint (SUR): Blood pressure
Study 12658059 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9024279 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 17496226 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 26549402 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 26549402 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 6185209 — Predictive Biomarker (PRD): BLM mRNA
Genes: BLM; RECQ2; RECQL3
Study 27159993 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 20005375 — Safety Biomarker (SAF): Prognostic nutrition index
Study 2353183 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 31727676 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 25927321 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 16595614 — Surrogate Endpoint (SUR): Blood pressure
Study 14609606 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14609606 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26284918 — Surrogate Endpoint (SUR): Blood pressure
Study 23471469 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 18211600 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 17012138 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 10740141 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30043449 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 15588161 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15588161 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 15588161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): IL1B
Genes: IL1F2; IL-1B; IL1-BETA
Study 2297349 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7002197 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24007456 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 24007456 — Surrogate Endpoint (SUR): Blood pressure
Study 9402071 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22946930 — Surrogate Endpoint (SUR): Bone mineral density
Study 1334819 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 2183665 — Surrogate Endpoint (SUR): Serum creatinine
Study 2183665 — Surrogate Endpoint (SUR): Serum potassium
Study 25173538 — Surrogate Endpoint (SUR): Blood pressure
Study 15099990 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study 15099990 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 22840286 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study 22840286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 22840286 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 22840286 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 22840286 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21294631 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19321562 — Surrogate Endpoint (SUR): Blood pressure
Study 11592726 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 27765800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 18327581 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25385260 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15223858 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 23185261 — Surrogate Endpoint (SUR): Bone mineral density
Study 28636851 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 26289514 — Surrogate Endpoint (SUR): Blood pressure
Study 20374312 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20374312 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9612832 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 25879008 — Surrogate Endpoint (SUR): Blood pressure
Study 20110026 — Surrogate Endpoint (SUR): Blood pressure
Study 17275927 — Predictive Biomarker (PRD): CARD16 mRNA
Genes: CARD16; COP; COP1
Study 15533270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9491823 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 31320177 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 31320177 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26287302 — Surrogate Endpoint (SUR): Blood pressure
Study 23453104 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 23453104 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study 23453104 — Surrogate Endpoint (SUR): Blood pressure
Study 16143706 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 1822966 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24321717 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 1508060 — Surrogate Endpoint (SUR): Bone mineral density
Study 30557377 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 27803393 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24671507 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24671507 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24671507 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31084684 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23927461 — Surrogate Endpoint (SUR): Blood pressure
Study 15613919 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 3098194 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 3098194 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 15877999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 6507951 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 26948466 — Surrogate Endpoint (SUR): Blood pressure
Study 20592128 — Surrogate Endpoint (SUR): Bone mineral density
Study 18801505 — Surrogate Endpoint (SUR): Serum testosterone
Study 15695129 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15695129 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12061948 — Surrogate Endpoint (SUR): Forced vital capacity
Study 27424812 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25122422 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 25122422 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study 20122035 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 20122035 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 26988693 — Surrogate Endpoint (SUR): Blood pressure
Study 26988693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23828292 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 23828292 — Safety Biomarker (SAF): BDNF
Study 19118696 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19118696 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 16409564 — Surrogate Endpoint (SUR): Blood pressure
Study 11480712 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 30184103 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 24108668 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 17315118 — Surrogate Endpoint (SUR): Blood pressure
Study 8436151 — Surrogate Endpoint (SUR): Blood pressure
Study 20231198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15766995 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15766995 — Surrogate Endpoint (SUR): Blood pressure
Study 1961962 — Surrogate Endpoint (SUR): Blood pressure
Study 6118333 — Surrogate Endpoint (SUR): Blood pressure
Study 6118333 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 21851876 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 21851876 — Surrogate Endpoint (SUR): Serum creatinine
Study 21851876 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 19318693 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 19263563 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 16911680 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 29174316 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 23033863 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 17353866 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 2851172 — Predictive Biomarker (PRD): TIMM8A mRNA
Genes: TIMM8A; DDP; DDP1; TIM8A
Study 3376710 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 30442868 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 23153742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23153742 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23153742 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20667439 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 20667439 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 18986531 — Surrogate Endpoint (SUR): Bone mineral density
Study 28509725 — Surrogate Endpoint (SUR): Blood pressure
Study 23336628 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 20359723 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26295664 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 12923404 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12923404 — Surrogate Endpoint (SUR): Serum creatinine
Study 31902311 — Surrogate Endpoint (SUR): Blood pressure
Study 29788230 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29788230 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study 29788230 — Predictive Biomarker (PRD): NOTCH3 mRNA
Genes: NOTCH3
Study 16239629 — Surrogate Endpoint (SUR): Blood pressure
Study 16980814 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 16980814 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 12562461 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 23557025 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 23557025 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 12539808 — Surrogate Endpoint (SUR): Serum triglycerides
Study 12539808 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12539808 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24371832 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24371832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24371832 — Surrogate Endpoint (SUR): Blood pressure
Study 24371832 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24371832 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 20056852 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 20056852 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 23188412 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 23188412 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study 23188412 — Predictive Biomarker (PRD): HAS2 mRNA
Genes: HAS2
Study 12662915 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 27230965 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study 10605328 — Surrogate Endpoint (SUR): Blood pressure
Study 1932652 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 1932652 — Safety Biomarker (SAF): Glutamate dehydrogenase
Study 15947981 — Surrogate Endpoint (SUR): Serum creatinine
Study 6725520 — Surrogate Endpoint (SUR): Blood pressure
Study 29889157 — Surrogate Endpoint (SUR): Blood pressure
Study 27344826 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 25012999 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 20484057 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 20484057 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20484057 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20484057 — Surrogate Endpoint (SUR): Blood pressure
Study 15975721 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7617798 — Surrogate Endpoint (SUR): Blood pressure
Study 28374923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23617452 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 29509864 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 22559218 — Surrogate Endpoint (SUR): Blood pressure
Study 20130470 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17335685 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 26169045 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 14692130 — Surrogate Endpoint (SUR): Blood pressure
Study 30133478 — Monitoring Biomarker (MOI): HBV DNA
Study 26728480 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 22832839 — Surrogate Endpoint (SUR): Blood pressure
Study 12881158 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 531563 — Surrogate Endpoint (SUR): Blood pressure
Study 2846791 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 15967861 — Surrogate Endpoint (SUR): Serum creatinine
Study 11817593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11817593 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 15179967 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 2554722 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 240014 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 19563976 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24008128 — Predictive Biomarker (PRD): ALDH1A1 mRNA
Genes: ALDH1A1; ALDC; ALDH1; PUMB1
Study 8225214 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 3877279 — Surrogate Endpoint (SUR): Blood pressure
Study 29654415 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29654415 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29654415 — Predictive Biomarker (PRD): Hormone receptor
Study 26843523 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 24709267 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 22672732 — Surrogate Endpoint (SUR): Forced vital capacity
Study 10344212 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 7159500 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30536182 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24848974 — Surrogate Endpoint (SUR): Bone mineral density
Study 24848974 — Safety Biomarker (SAF): Bacteroidetes phylum
Study 18394931 — Surrogate Endpoint (SUR): Blood pressure
Study 7489182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26061039 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 23134234 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 19706737 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10924776 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 7032554 — Surrogate Endpoint (SUR): Blood pressure
Study 30641762 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30641762 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 25988317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25988317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25988317 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25988317 — Safety Biomarker (SAF): BDNF
Study 23146973 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15542042 — Surrogate Endpoint (SUR): Bone mineral density
Study 11479482 — Surrogate Endpoint (SUR): Blood pressure
Study 9104574 — Surrogate Endpoint (SUR): Blood pressure
Study 27617661 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 27617661 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 21959915 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 30553760 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 23530022 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 21272454 — Monitoring Biomarker (MOI): HBV DNA
Study 17605253 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study 15127239 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9783295 — Surrogate Endpoint (SUR): Blood pressure
Study 22963881 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study 22963881 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 17922185 — Predictive Biomarker (PRD): Hormone receptor
Study 16820790 — Surrogate Endpoint (SUR): Serum creatinine
Study 9181182 — Surrogate Endpoint (SUR): Blood pressure
Study 31729647 — Surrogate Endpoint (SUR): Serum uric acid
Study 28065445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17133785 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 15612454 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 8389339 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 3040455 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 3040455 — Surrogate Endpoint (SUR): Blood pressure
Study 28959158 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28959158 — Surrogate Endpoint (SUR): Blood pressure
Study 21647425 — Surrogate Endpoint (SUR): Blood pressure
Study 19665601 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 19665601 — Surrogate Endpoint (SUR): Bone mineral density
Study 31747840 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30852481 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18156492 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 18156492 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 9797758 — Predictive Biomarker (PRD): ARID3B mRNA
Genes: ARID3B; BDP; DRIL2
Study 27394691 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 25016757 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25016757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9815827 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 9815827 — Predictive Biomarker (PRD): MARCKSL1 mRNA
Genes: MARCKSL1; MLP; MRP
Study 24244687 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 24244687 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 29125017 — Surrogate Endpoint (SUR): Bone mineral density
Study 28288570 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 28288570 — Surrogate Endpoint (SUR): Blood pressure
Study 16796925 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16796925 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16796925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31983653 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31983653 — Surrogate Endpoint (SUR): Blood pressure
Study 28033332 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 22865016 — Surrogate Endpoint (SUR): Blood pressure
Study 15855334 — Predictive Biomarker (PRD): TBC1D4 mRNA
Genes: TBC1D4; AS160; KIAA0603
Study 15855334 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 15855334 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 12208438 — Surrogate Endpoint (SUR): Blood pressure
Study 1828191 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 29242062 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 3103546 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 28346912 — Predictive Biomarker (PRD): OCLN mRNA
Genes: OCLN
Study 26058417 — Surrogate Endpoint (SUR): Blood pressure
Study 19923069 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19923069 — Surrogate Endpoint (SUR): Blood pressure
Study 17288832 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1